Prestige Wealth Management Group LLC Gsk PLC Transaction History

Prestige Wealth Management Group LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 17, 2021	SELL	$34.07 - $39.94 $817 - $958	-24 Reduced 10.71%	200 $7,000
Q2 2020 Aug 13, 2020	SELL	$37.87 - $43.58 $189 - $217	-5 Reduced 2.18%	224 $9,000
Q1 2020 May 15, 2020	SELL	$32.47 - $48.83 $14,546 - $21,875	-448 Reduced 66.17%	229 $9,000
Q4 2019 Jan 28, 2020	BUY	$42.0 - $48.25 $1,176 - $1,351	28 Added 4.31%	677 $31,000
Q2 2019 Aug 16, 2019	SELL	$39.4 - $42.7 $669 - $725	-17 Reduced 2.55%	649 $26,000
Q1 2019 Aug 16, 2019	BUY	$38.57 - $42.69 $3,355 - $3,714	87 Added 15.03%	666 $27,000
Q4 2018 Apr 16, 2019	BUY	$37.8 - $42.69 $21,886 - $24,717	579 New	579 $22,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.4B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Prestige Wealth Management Group LLC, based on Form 13F filings with the SEC.

Stay updated on Prestige Wealth Management Group LLC with notifications on news.